Search Results - "Puigdefàbregas, Lluis"

Cell free circulating tumor DNA in cerebrospinal fluid detects and monitors central nervous system involvement of B-cell lymphomas by Bobillo, Sabela, Crespo, Marta, Escudero, Laura, Mayor, Regina, Raheja, Priyanka, Carpio, Cecilia, Rubio-Perez, Carlota, Tazón-Vega, Bárbara, Palacio, Carlos, Carabia, Júlia, Jiménez, Isabel, Nieto, Juan C, Montoro, Julia, Martínez-Ricarte, Francisco, Castellvi, Josep, Simó, Marc, Puigdefàbregas, Lluis, Abrisqueta, Pau, Bosch, Francesc, Seoane, Joan

“…The levels of cell free circulating tumor DNA (ctDNA) in plasma correlated with treatment response and outcome in systemic lymphomas. Notably, in brain tumors,…”
Get full text

Posttransplant cyclophosphamide after allogeneic hematopoietic cell transplantation mitigates the immune activation induced by previous nivolumab therapy by Nieto, Juan C., Roldán, Elisa, Jiménez, Isabel, Fox, Laura, Carabia, Júlia, Ortí, Guillermo, Puigdefàbregas, Lluís, Gallur, Laura, Iacoboni, Gloria, Raheja, Priyanka, Pérez, Ana, Bobillo, Sabela, Salamero, Olga, Palacio, Carlos, Valcárcel, David, Crespo, Marta, Bosch, Francesc, Barba, Pere

“…Patients receiving an allogeneic hematopoietic cell transplantation (allo-HCT) after the use of PD-1 inhibitors seem to be at a higher risk of developing acute…”
Get full text

Repolarization of tumor infiltrating macrophages and increased survival in mouse primary CNS lymphomas after XPO1 and BTK inhibition by Jiménez, Isabel, Carabia, Júlia, Bobillo, Sabela, Palacio, Carles, Abrisqueta, Pau, Pagès, Carlota, Nieto, Juan C., Castellví, Josep, Martínez-Ricarte, Francisco, Escoda, Lourdes, Perla, Cristóbal, Céspedes Torrez, Dennis H., Boix, Joan, Purroy, Noelia, Puigdefàbregas, Lluís, Seoane, Joan, Bosch, Francesc, Crespo, Marta

“…Background Patients diagnosed with primary central nervous system lymphoma (PCNSL) often face dismal outcomes due to the limited availability of therapeutic…”
Get full text

Immunological and genetic kinetics from diagnosis to clinical progression in chronic lymphocytic leukemia by Jiménez, Isabel, Tazón-Vega, Bárbara, Abrisqueta, Pau, Nieto, Juan C, Bobillo, Sabela, Palacio-García, Carles, Carabia, Júlia, Valdés-Mas, Rafael, Munuera, Magdalena, Puigdefàbregas, Lluís, Parra, Genís, Esteve-Codina, Anna, Franco-Jarava, Clara, Iacoboni, Gloria, Terol, María José, García-Marco, José Antonio, Crespo, Marta, Bosch, Francesc

“…Mechanisms driving the progression of chronic lymphocytic leukemia (CLL) from its early stages are not fully understood. The acquisition of molecular changes…”
Get full text

Graft-Versus-Host Disease (GVHD) Prophylaxis with Post-Transplant Cyclophosphamide (PTCY) Induces a More Tolerant Immune Response after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) in Patients Previously Exposed to Nivolumab by Nieto, Juan C, Roldan, Elisa, Jiménez, Isabel, Fox, Laura, Carabia, Júlia, Orti, Guillermo, Puigdefàbregas, Lluis, Gallur, Laura, Iacoboni, Gloria, Raheja, Priyanka, Perez, Ana, Salamero, Olga, Palacio, Carlos, Valcarcel, David, Crespo, Marta, Bosch, Francesc, Barba, Pere

“…Allo-HCT has been shown to be feasible in patients previously exposed to anti-PD-1 monoclonal antibodies, albeit their use has been associated with a more…”
Get full text

Clinical Progression of Chronic Lymphocytic Leukemia (CLL) Is Characterized By a Progressive Increase of the Exhausted T-Cell Phenotype and Immunosuppression Induced By Leukemic Cells by Jiménez, Isabel, Bobillo, Sabela, Abrisqueta, Pau, Tazón, Bárbara, Palacio, Carles, Nieto, Juan C, Carabia, Júlia, Terol, Maria Jose, Garcia-Marco, Jose, Boix, Joan, Munuera, Magdalena, Puigdefàbregas, Lluis, Roldán, Elisa, Crespo, Marta, Bosch, Francesc

“…The mechanisms leading to clinical progression of CLL from early asymptomatic stages are not fully elucidated, being the acquisition of molecular alterations…”
Get full text